Back to Search
DAVID ODENHEIMER, MD, PHD
MD, PHD
Student in an Organized Health Care Education/Training Program
NPI: 1841094570Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (4)
Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
PMID 15623608·Clin Cancer Res·2004
3-trial
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
PMID 12786629·Aliment Pharmacol Ther·2003
3-trial
Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.
PMID 12102617·AAPS PharmSci·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2021 PERDIDO STREET, CALS BUILDING ROOM 6158
NEW ORLEANS, LA 70112 - Phone
- (504) 568-4080
Quick Facts
- NPI
- 1841094570
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 4
Are you this provider?
Claim Your Profile